IntegraGen announced unaudited revenue results for the full year 2022. The 2022 unaudited revenue amount to EUR 12,592,000 in 2022, representing an increase of 16% compared to 2021. This growth in all activities reflects the firmness of the company's positioning, both in terms of its main sequencing activities for R&D customers and its expertise in operating platforms on behalf of third parties.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 EUR | 0.00% | +4.69% | -25.06% |
May. 01 | IntegraGen SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-25.06% | 4.81M | |
-36.44% | 9.2B | |
-3.29% | 3.12B | |
+19.31% | 2.8B | |
-18.71% | 2.07B | |
-22.03% | 1.59B | |
+64.58% | 1.44B | |
+34.58% | 830M | |
-7.42% | 724M | |
-25.51% | 507M |
- Stock Market
- Equities
- ALINT Stock
- News IntegraGen
- IntegraGen Announces Unaudited Revenue Results for the Full Year 2022